Alec Stranahan
Stock Analyst at Bank of America Securities
(3.38)
# 2,380
Out of 5,004 analysts
634
Total ratings
46.8%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Reiterated: Buy | $46 → $50 | $32.58 | +53.47% | 35 | Sep 21, 2026 | |
| CADL Candel Therapeutics | Upgraded: Buy | $12 → $18 | $11.02 | +63.34% | 19 | Sep 21, 2026 | |
| HCM HUTCHMED (China) | Reiterated: Buy | $16 → $18 | $14.01 | +28.48% | 24 | Sep 21, 2026 | |
| KRYS Krystal Biotech | Reiterated: Buy | $392 → $400 | $345.82 | +15.67% | 33 | Sep 21, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $15 | $7.40 | +102.70% | 30 | Sep 21, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $225 → $265 | $204.97 | +29.29% | 38 | Sep 21, 2026 | |
| RXRX Recursion Pharmaceuticals | Reiterated: Hold | n/a | $3.74 | - | 25 | Sep 21, 2026 | |
| XNCR Xencor | Reiterated: Hold | $20 → $26 | $23.80 | +9.24% | 20 | Sep 21, 2026 | |
| MRNA Moderna | Reiterated: Hold | $170 | $198.88 | -14.52% | 27 | Sep 18, 2026 | |
| NVAX Novavax | Reiterated: Sell | $7 | $10.63 | -34.15% | 43 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.65 | +384.85% | 2 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $24.27 | +77.17% | 25 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $14.25 | +40.35% | 28 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $8.37 | +103.11% | 18 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $19.43 | +74.99% | 9 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $2.52 | +98.41% | 18 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $1.24 | +303.23% | 16 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $10.91 | +74.15% | 17 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $2.95 | +103.74% | 13 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.78 | +349.74% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $1.95 | -48.72% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $15.47 | +126.24% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $88 | $67.15 | +31.05% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.58 | - | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $22 | $16.30 | +34.97% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $11.75 | +44.68% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $10.66 | +40.71% | 21 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $82 | $54.23 | +51.21% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 → $21 | $57.43 | -63.43% | 38 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $0.0384 | +2,504.17% | 1 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $800 → $565 | $788.04 | n/a | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,150 → $1,100 | $1,183.46 | n/a | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $20.66 | n/a | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $1 | $5.08 | n/a | 4 | Dec 2, 2022 |
Agios Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $46 → $50
Current: $32.58
Upside: +53.47%
Candel Therapeutics
Sep 21, 2026
Upgraded: Buy
Price Target: $12 → $18
Current: $11.02
Upside: +63.34%
HUTCHMED (China)
Sep 21, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $14.01
Upside: +28.48%
Krystal Biotech
Sep 21, 2026
Reiterated: Buy
Price Target: $392 → $400
Current: $345.82
Upside: +15.67%
REGENXBIO
Sep 21, 2026
Reiterated: Buy
Price Target: $15
Current: $7.40
Upside: +102.70%
Revolution Medicines
Sep 21, 2026
Reiterated: Buy
Price Target: $225 → $265
Current: $204.97
Upside: +29.29%
Recursion Pharmaceuticals
Sep 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.74
Upside: -
Xencor
Sep 21, 2026
Reiterated: Hold
Price Target: $20 → $26
Current: $23.80
Upside: +9.24%
Moderna
Sep 18, 2026
Reiterated: Hold
Price Target: $170
Current: $198.88
Upside: -14.52%
Novavax
Sep 18, 2026
Reiterated: Sell
Price Target: $7
Current: $10.63
Upside: -34.15%
Sep 10, 2026
Reiterated: Buy
Price Target: $8
Current: $1.65
Upside: +384.85%
Sep 8, 2026
Reiterated: Buy
Price Target: $43
Current: $24.27
Upside: +77.17%
Aug 26, 2026
Reiterated: Hold
Price Target: $20
Current: $14.25
Upside: +40.35%
Aug 18, 2026
Reiterated: Buy
Price Target: $17
Current: $8.37
Upside: +103.11%
Aug 14, 2026
Reiterated: Buy
Price Target: $34
Current: $19.43
Upside: +74.99%
Aug 14, 2026
Reiterated: Hold
Price Target: $6 → $5
Current: $2.52
Upside: +98.41%
Aug 14, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $1.24
Upside: +303.23%
Aug 14, 2026
Reiterated: Buy
Price Target: $19
Current: $10.91
Upside: +74.15%
Aug 14, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $2.95
Upside: +103.74%
Aug 12, 2026
Reiterated: Buy
Price Target: $17
Current: $3.78
Upside: +349.74%
Aug 7, 2026
Reiterated: Sell
Price Target: $1
Current: $1.95
Upside: -48.72%
Aug 7, 2026
Reiterated: Buy
Price Target: $35
Current: $15.47
Upside: +126.24%
Aug 7, 2026
Reiterated: Buy
Price Target: $87 → $88
Current: $67.15
Upside: +31.05%
Aug 7, 2026
Reiterated: Sell
Price Target: n/a
Current: $2.58
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: $21 → $22
Current: $16.30
Upside: +34.97%
Aug 7, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $11.75
Upside: +44.68%
Aug 7, 2026
Reiterated: Buy
Price Target: $16 → $15
Current: $10.66
Upside: +40.71%
Aug 5, 2026
Reiterated: Buy
Price Target: $83 → $82
Current: $54.23
Upside: +51.21%
Aug 5, 2026
Reiterated: Sell
Price Target: $20 → $21
Current: $57.43
Upside: -63.43%
Mar 27, 2026
Reiterated: Sell
Price Target: $1
Current: $0.0384
Upside: +2,504.17%
Dec 10, 2024
Initiated Coverage: Sell
Price Target: $800 → $565
Current: $788.04
Upside: n/a
Nov 1, 2024
Rated: Buy
Price Target: $1,150 → $1,100
Current: $1,183.46
Upside: n/a
Aug 15, 2023
Reiterated: Buy
Price Target: $6 → $5
Current: $20.66
Upside: n/a
Dec 2, 2022
Reiterated: Sell
Price Target: $10 → $1
Current: $5.08
Upside: n/a